Comparison of the Effect of Dexmedetomidine, Remifentanil and Metoral on Reducing Bleeding and Surgery Satisfaction During Rhinoplasty

Determination of the effect of Dexmedetomidine, Remifentanil and Metoral on reducing patient's hemorrhage and surgery satisfaction during rhinoplasty

This study is a double-blind randomized clinical trial of patients undergoing rhinoplasty candidate . After the anesthetic induction, the patients were placed under the ventilator and ready for rhinoplasty. Subsequently, for the patients in the first group, 0.5 mg / kg / h dose of dexmedetomidine in the second group, 50-100 μm / kg / hr Fentanil and in the third group, 50 mg Metoral will be infused.

This study is a double-blind randomized clinical trial of patients undergoing rhinoplasty candidate referring to Amirkabir Hospital in Arak. After the anesthetic induction, the patients were placed under the ventilator and ready for rhinoplasty. Subsequently, for the patients in the first group, 0.5 mg / kg / h dose of dexmedetomidine in the second group, 50-100 μm / kg / hr Fentanil and in the third group, 50 mg Metoral will be infused.

Entry: All patients with rhinoplasty candidates referring to Amir Kabir Hospital, patients aged 18 to 50 years and all patients undergoing surgery by a surgeon. No entery: Patients who have a cardiogenic disorder during operation or even have a heart arrest A respiratory arrest has occurred to them

Subsequently, for the patients in the first group, 0.5 mg / kg / h dose of dexmedetomidine in the second group, 50-100 μm / kg / hr Fentanil and in the third group, 50 mg Metoral will be infused.

For all of the patients in the three groups, a questionnaire including demographic information, as well as data on MAP, PR, mean score of bleeding, controlled hypotension, and the rate of rhythm and morbidity and mortality were completed.

This study is a double-blind randomized clinical trial of patients undergoing rhinoplasty in the Amir Kabir hospital of Arak. A sample of 75 patients with a candidate rhinoplasty that has been studied by a cardiologist and selected by a cardiologist is selected and divided into three randomly assigned randomized complete sets randomly divided into three groups: Remifentanil, Metoral, and Dexmedetomidine.

The drugs required for infusion are prepared for anesthetist by the anesthetist and in each of the 3 groups 50 cc syringes are provided with a similar appearance to the partner in order to provide infusion to the patients. also intern responsible for the plan who is responsible for completing the questionnaire, is not aware of the type of study group. Syringes containing infusion solutions are placed on the A, B, and C adhesives for the patients, provided with a syringe A, B and C.